Haoxi Health Technology Ltd
HAO · Services-Advertising Agencies · EDGAR filings ↗
Reference price $0.02 — last insider purchase, 2026-05-19 (estimated from the dated SEC Form 4 price — not a live quote)
Grade
B76gen composite 66pct→76
Notable findings
- Revenue declineRevenue -32.4% YoY
Key metrics
Gross margin
2.8%
Operating margin
-6.1%
Net margin
11.8%
Return on equity
22.3%
Return on assets
18.0%
ROIC
-8.8%
Revenue growth (QoQ)
-32.4%
Net-income growth
200.1%
Debt / equity
0.0×
Current ratio
5.0×
Tangible book value
$16M
Cash & investments
$9M
Stock comp / revenue
0.2%
Leadership & compensation
| Name | Role | Latest total comp |
|---|---|---|
| Fan Zhen | CEO & Chairman | — |
Officers & directors from SEC filings (Form 4 + DEF 14A proxy); compensation is the latest reported fiscal year.
Insider transactions · last 6 months
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-05-19 | Fan Zhen | Buy | 40.0M | $0.02 |
All non-derivative Form 4 activity (SEC), newest first.
Recent filings
| Form | Filed | Period | Accession |
|---|---|---|---|
| 20-F | 2025-10-20 | 2025-06-30 | 0001213900-25-100369 ↗ |
| 20-F | 2024-10-29 | 2024-06-30 | 0001213900-24-091443 ↗ |